(Q38454850)

3 September 2017

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe (English)

1 reference

3 September 2017

1 reference

4

Christian Drosten

1 reference

3 September 2017

W Kurt Roth

1

1 reference

3 September 2017

Marijke Weber

2

1 reference

3 September 2017

Sylvia Buhr

3

1 reference

3 September 2017

Wolfgang Weichert

5

1 reference

3 September 2017

Walid Sireis

6

1 reference

3 September 2017

Doris Hedges

7

1 reference

3 September 2017

Erhard Seifried

8

1 reference

3 September 2017

1 July 2002

1 reference

3 September 2017

1 reference

3 September 2017

42

1 reference

3 September 2017

862-868

1 reference

3 September 2017

7

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

3 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

Optimal blood donation screening annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00129.X

10.1046/J.1537-2995.2002.00129.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference